CLDN6 and hepatocellular carcinoma: Our recently published study [28] found another oncofetal driver, Claudin6 (CLDN6), which has a dynamic expression pattern similar to that of CHD1L, as a potential therapeutic target correlated with HCC lineage plasticity.